BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 7851963)

  • 1. Macrophage priming and activation during fibrosarcoma growth: expression of c-myb, c-myc, c-fos, and c-fms.
    Alleva DG; Askew D; Burger CJ; Elgert KD
    Immunol Invest; 1994 Nov; 23(6-7):457-72. PubMed ID: 7851963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased sensitivity of tumor-bearing host macrophages to interleukin-10: a counter-balancing action to macrophage-mediated suppression.
    Alleva DG; Burger CJ; Elgert KD
    Oncol Res; 1994; 6(4-5):219-28. PubMed ID: 7841545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-induced modulation of macrophage class II MHC molecule mRNA expression.
    Askew D; Burger CJ; Elgert KD
    Mol Immunol; 1993 Jul; 30(10):911-20. PubMed ID: 8341283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrosarcoma-induced increase in macrophage tumor necrosis factor alpha synthesis suppresses T cell responses.
    Alleva DG; Askew D; Burger CJ; Elgert KD
    J Leukoc Biol; 1993 Aug; 54(2):152-60. PubMed ID: 8360594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
    Gogusev J; Barbey S; Nezelof C
    Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophages stimulated by receptor-ligand interactions exhibit differences in cell-cycle kinetics during tumor growth: stimulation at Mac-1 and Mac-3 receptors alters DNA synthesis.
    Walker TM; Yurochko AD; Burger CJ; Elgert KD
    Immunol Lett; 1992 Feb; 31(3):217-25. PubMed ID: 1548036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor growth increases Ia- macrophage synthesis of tumor necrosis factor-alpha and prostaglandin E2: changes in macrophage suppressor activity.
    Alleva DG; Burger CJ; Elgert KD
    J Leukoc Biol; 1993 May; 53(5):550-8. PubMed ID: 8388910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endotoxin and interferon-gamma differentially regulate the transcriptional levels of proto-oncogenes and cytokine genes during the differentiation of colony-stimulating factor type-1-derived macrophages.
    Myers MJ; Ghildyal N; Schook LB
    Immunology; 1995 Jun; 85(2):318-24. PubMed ID: 7642223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour growth causes suppression of autoreactive T-cell proliferation by disrupting macrophage responsiveness to interferon-gamma.
    Alleva DG; Burger CJ; Elgert KD
    Scand J Immunol; 1994 Jan; 39(1):31-8. PubMed ID: 7904773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-induced macrophage tumor necrosis factor-alpha production suppresses autoreactive T cell proliferation.
    Alleva DG; Burger CJ; Elgert KD
    Immunobiology; 1993 Aug; 188(4-5):430-45. PubMed ID: 8244447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor growth and adherence change the expression of macrophage Mac-2.
    Askew D; Burger CJ; Elgert KD
    Cancer Lett; 1993 Apr; 69(1):67-74. PubMed ID: 8481895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal and tumor-bearing host macrophage responses: variability in accessory function, surface markers, and cell-cycle kinetics.
    Askew D; Yurochko AD; Burger CJ; Elgert KD
    Immunol Lett; 1990; 24(1):21-9. PubMed ID: 1695610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal and tumor-bearing host splenic macrophage responses to lipopolysaccharide.
    Yurochko AD; Askew D; Burger CJ; Elgert KD
    Immunol Invest; 1990 Feb; 19(1):41-55. PubMed ID: 1692569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of macrophage suppressor activity by fibrosarcoma-derived transforming growth factor-beta 1: contrasting effects on resting and activated macrophages.
    Alleva DG; Walker TM; Elgert KD
    J Leukoc Biol; 1995 Jun; 57(6):919-28. PubMed ID: 7790775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of nuclear proto-oncogenes in T cells triggered with mitogenic and nonmitogenic T3 and T11 activation signals.
    Shipp MA; Reinherz EL
    J Immunol; 1987 Oct; 139(7):2143-8. PubMed ID: 2821108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor modulation of autoreactivity: decreased macrophage and autoreactive T cell interactions.
    Yurochko AD; Burger CJ; Elgert KD
    Cell Immunol; 1990 Apr; 127(1):105-19. PubMed ID: 2138515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proto-oncogene expression and dissection of the myeloid growth to differentiation developmental cascade.
    Liebermann DA; Hoffman-Liebermann B
    Oncogene; 1989 May; 4(5):583-92. PubMed ID: 2471131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of monocytic differentiation and modulation of the expression of c-fos, c-fms and c-myc protooncogenes in human monoblasts by cytokines and phorbolester.
    Brach MA; Riedel D; Herrmann F
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1990; 59(1):54-8. PubMed ID: 1696041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promotion of macrophage-stimulated autoreactive T cell proliferation by interleukin-10: counteraction of macrophage suppressor activity during tumor growth.
    Alleva DG; Elgert KD
    Immunobiology; 1995 Feb; 192(3-4):155-71. PubMed ID: 7782092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor growth alters T cell and macrophage production of and responsiveness to granulocyte-macrophage colony-stimulating factor: partial dysregulation through interleukin-10.
    Walker TM; Burger CJ; Elgert KD
    Cell Immunol; 1994 Apr; 154(1):342-57. PubMed ID: 8131207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.